Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-1611-2014

Drug recall · October 8, 2014

CREON (pancrelipase) Delayed-Release Capsules recall

Why: Presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only. Marketed by: AbbVie Inc., North Chicago, IL 60064, Product of Germany. NDC 0032-1224-07.

Lots / codes

Lot #: 1020156; Expiry: 3/31/2016

Quantity
18,021 Bottles
Company
AbbVie Inc, North Chicago, IL
Distribution
US: Nationwide
Initiated
September 15, 2014 · Voluntary: Firm initiated
Classified
September 26, 2014
Reported
October 8, 2014
Ended
June 22, 2016
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Creon

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.